OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action
Aina Akmal Mohd Noor, Maryam Azlan, Norhanani Mohd Redzwan
Biomedicines (2022) Vol. 10, Iss. 2, pp. 498-498
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Tetrastigma hemsleyanum Polysaccharides Alleviate Imiquimod-Induced Psoriasis-Like Skin Lesions in Mice by Modulating the JAK/STAT3 Signaling Pathway
Yishan Lv, Yang Liu, Zian Mao, et al.
Phytomedicine (2024) Vol. 133, pp. 155917-155917
Closed Access | Times Cited: 11

Identification and mechanistic insights of cell senescence-related genes in psoriasis
Guiyan Deng, Cheng‐Jian Xu, Dun‐Chang Mo
PeerJ (2025) Vol. 13, pp. e18818-e18818
Open Access | Times Cited: 1

Biologic Therapies Decrease Disease Severity and Improve Depression and Anxiety Symptoms in Psoriasis Patients
Teodora-Larisa Timiș, Lehel Beni, Teodora Mocan, et al.
Life (2023) Vol. 13, Iss. 5, pp. 1219-1219
Open Access | Times Cited: 15

Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
Dorota Purzycka-Bohdan, Bogusław Nedoszytko, Monika Zabłotna, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13330-13330
Open Access | Times Cited: 18

Current and emerging prospects in the psoriatic treatment
Rutuja Vilas Nikam, M Gowtham, Pratiksha Sanjay More, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110331-110331
Closed Access | Times Cited: 10

Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study
Federico Diotallevi, Giulia Matacchione, Anna Campanati, et al.
Dermatology and Therapy (2025)
Open Access

In Silico based-molecular Screening and Evaluation of In-vivo Anti-inflammatory activity of selected medicinal herbs for Psoriasis management
Prativa Biswasroy, Deepak Pradhan, Dilip Kumar Pradhan, et al.
Research Journal of Pharmacy and Technology (2025), pp. 1743-1749
Closed Access

Hypoxia-induced RHCG as a key regulator in psoriasis and its modulation by secukinumab
Shun Guo, Qian Zhang, Yuan-jie Liu, et al.
APL Bioengineering (2025) Vol. 9, Iss. 2
Open Access

Activity of hydrogel-vitamin D3 /bacterioruberin nanoparticles on imiquimod-induced fibroblasts-keratinocytes spheroids
Yamila Roxana Simioni, Federico Ricatti, Andrés G. Salvay, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105738-105738
Closed Access | Times Cited: 3

Modulation of the skin and gut microbiome by psoriasis treatment: a comprehensive systematic review
A. A. Korneev, Maria Peshkova, Polina I. Koteneva, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Closed Access | Times Cited: 3

The Expression of Cytokines and Chemokines Potentially Distinguishes Mild and Severe Psoriatic Non-Lesional and Resolved Skin from Healthy Skin and Indicates Different Stages of Inflammation
Renáta Bozó, Lili Borbála Flink, Barbara Ambrus, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11292-11292
Open Access | Times Cited: 3

The immunological understanding on germinal center B cells in psoriasis
Aina Akmal Mohd Noor, Abdah Karimah Che Md Nor, Norhanani Mohd Redzwan
Journal of Cellular Physiology (2024) Vol. 239, Iss. 6
Closed Access | Times Cited: 2

Inflammatory Cytokines and Clinical Outcome Following Biological Therapy in Adult Bio-Naïve Psoriasis Patients
Teodora-Larisa Florian, Ioan Alexandru Florian, Ștefan Cristian Vesa, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 7719-7729
Open Access | Times Cited: 2

Keratinocyte proline‐rich protein modulates immune and epidermal response in imiquimod‐induced psoriatic skin inflammation
Ai Matsuno, Hayakazu Sumida, Hirofumi Nakanishi, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 12, pp. 2121-2130
Open Access | Times Cited: 6

Topical anti-TNF-a ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB/c mice
Saeideh Sadat Shobeiri, Mohammadreza Dashti, Safoora Pordel, et al.
Cytokine (2023) Vol. 172, pp. 156406-156406
Closed Access | Times Cited: 5

Inhibition of Key Glycolytic Enzyme Hexokinase 2 Ameliorates Psoriasiform Inflammation in vitro and in vivo
Le Zhuang, Weiyuan Ma, Jing Jiao
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3229-3239
Open Access | Times Cited: 4

Anti‐Cytokine Active Immunotherapy Based on Supramolecular Peptides for Alleviating IL‐1β‐Mediated Inflammation
Shamitha Shetty, Yaoying Wu, Christopher Z. Lloyd, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 1

Systematic optimization, characterization of Mycophenolic acid loaded nanostructured lipid carrier embedd ed nanogel for improved permeation and in vivo antipsoriatic activity
Payal Kesharwani, Akansha Bisht, Mayank Handa, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105088-105088
Closed Access | Times Cited: 3

Fucosylation deficiency enhances imiquimod-induced psoriasis-like skin inflammation by promoting CXCL1 expression
Na Li, Youngae Lee, Joong Heon Suh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166988-166988
Open Access | Times Cited: 2

Molecular treatment trajectories within psoriatic T lymphocytes: a mini review
Martyna Kuczyńska, Magdalena Gabig‐Cimińska, Marta Moskot
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1

Insights into Autophagic Machinery and Lysosomal Function in Cells Involved in the Psoriatic Immune-Mediated Inflammatory Cascade
Martyna Kuczyńska, Marta Moskot, Magdalena Gabig‐Cimińska
Archivum Immunologiae et Therapiae Experimentalis (2024) Vol. 72, Iss. 1
Open Access

IFN-γ, IL-17A, IL-4, and IL-13: Potential Biomarkers for Prediction of the Effectiveness of Biologics in Psoriasis Patients
Ching‐Liang Hsieh, Sheng‐Jie Yu, Kuo‐Lung Lai, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1115-1115
Open Access

Intercommunicating avenues – cytokine networks in psoriasis Mihaela Surcel1, Adriana Narcisa Munteanu12,
Mihaela Surcel, Adriana Munteanu, Carolina Constantin, et al.
Journal of Cell Identity (2024) Vol. 3, Iss. 1
Closed Access

Page 1 - Next Page

Scroll to top